The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 24, 2016
Filed:
Jul. 10, 2014
Applicant:
Glycan Biosciences Llc, Corporate Centre, PA (US);
Inventors:
Warren Charles Kett, West Lebanon, NH (US);
Yugang Chen, Hanover, NH (US);
Assignee:
GLYCAN BIOSCIENCES LLC, Corporate Centre, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7036 (2006.01); C07H 15/23 (2006.01); C07H 15/232 (2006.01); C07H 15/224 (2006.01); C07H 15/234 (2006.01); C07H 15/238 (2006.01); A61K 31/702 (2006.01); A61K 31/7028 (2006.01); A61K 31/7034 (2006.01); A61K 31/7056 (2006.01); C07H 3/06 (2006.01); C07H 5/06 (2006.01); C07H 5/10 (2006.01); C07H 13/12 (2006.01); C07H 15/14 (2006.01); C07H 15/203 (2006.01); C07H 15/26 (2006.01); C07H 19/056 (2006.01); C07H 15/236 (2006.01);
U.S. Cl.
CPC ...
C07H 15/238 (2013.01); A61K 31/702 (2013.01); A61K 31/7028 (2013.01); A61K 31/7034 (2013.01); A61K 31/7036 (2013.01); A61K 31/7056 (2013.01); C07H 3/06 (2013.01); C07H 5/06 (2013.01); C07H 5/10 (2013.01); C07H 13/12 (2013.01); C07H 15/14 (2013.01); C07H 15/203 (2013.01); C07H 15/224 (2013.01); C07H 15/23 (2013.01); C07H 15/232 (2013.01); C07H 15/234 (2013.01); C07H 15/236 (2013.01); C07H 15/26 (2013.01); C07H 19/056 (2013.01);
Abstract
The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates to processes for the preparation of the conjugates. Such conjugates are useful in the prophylaxis and/or treatment of disease conditions and in particular chronic disease conditions such as inflammatory (including allergic) diseases, metastatic cancers and infection by pathogenic agents including bacteria, viruses or parasites.